应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02269 药明生物
已收盘 09-15 16:08:29
49.220
+0.080
+0.16%
最高
49.500
最低
48.200
成交量
2,435万
今开
49.140
昨收
49.140
日振幅
2.65%
总市值
2,046亿
流通市值
2,046亿
总股本
41.56亿
成交额
11.94亿
换手率
0.59%
流通股本
41.56亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | CRO概念股涨幅居前、凯莱英大涨12%,中报持续验证行业高景气,多家公司上调业绩指引
智通财经 · 09-14 13:34
港股异动 | CRO概念股涨幅居前、凯莱英大涨12%,中报持续验证行业高景气,多家公司上调业绩指引
港股早盘低开高走 恒生指数半日上涨0.35% 药明生物(02269)涨4.81%
金吾财讯 · 09-14 12:18
港股早盘低开高走 恒生指数半日上涨0.35% 药明生物(02269)涨4.81%
异动解读|药明生物盘中上涨3.06%,CXO板块集体走强带动反弹
行情直击 · 09-14 10:27
异动解读|药明生物盘中上涨3.06%,CXO板块集体走强带动反弹
医药板块表现强势 凯莱英(06821)涨超5% 机构制AI制药商业化风口初步显现
金吾财讯 · 09-14 10:26
医药板块表现强势 凯莱英(06821)涨超5% 机构制AI制药商业化风口初步显现
港股异动 | CRO概念股涨幅居前 中报持续验证行业高景气 多家公司上调业绩指引
智通财经 · 09-14 10:23
港股异动 | CRO概念股涨幅居前 中报持续验证行业高景气 多家公司上调业绩指引
异动解读|药明生物盘中下跌3.07%,报47.38港元
行情直击 · 09-10
异动解读|药明生物盘中下跌3.07%,报47.38港元
【券商聚焦】中信证券:中国创新药进入全球价值兑现阶段
金吾财讯 · 09-10
【券商聚焦】中信证券:中国创新药进入全球价值兑现阶段
药明生物:9月9日发行120万股并多次回购股份累计约3,982.45万股
公告速递 · 09-09
药明生物:9月9日发行120万股并多次回购股份累计约3,982.45万股
药明生物(02269.HK)因期权获行使而发行120万股
智通财经 · 09-09
药明生物(02269.HK)因期权获行使而发行120万股
创胜集团医药-B授予药明生物Hicb平台及Excelpro细胞培养基非独家许可
美股速递 · 09-09
创胜集团医药-B授予药明生物Hicb平台及Excelpro细胞培养基非独家许可
商务部新增84个全国重点外资项目
同花顺 · 09-08
商务部新增84个全国重点外资项目
药明生物自5月27日至7月7日回购3,982.45万股,涉资约12.72亿港元,并于9月7日发行180.41万股
公告速递 · 09-07
药明生物自5月27日至7月7日回购3,982.45万股,涉资约12.72亿港元,并于9月7日发行180.41万股
药明生物9月4日增发320万股并累计回购3982.45万股,耗资约12.72亿港元
公告速递 · 09-04
药明生物9月4日增发320万股并累计回购3982.45万股,耗资约12.72亿港元
药明生物(02269)因期权获行使而发行320万股
智通财经 · 09-04
药明生物(02269)因期权获行使而发行320万股
异动解读|药明生物盘中下跌3.12%,中期业绩兑现后板块回调压力延续
行情直击 · 09-04
异动解读|药明生物盘中下跌3.12%,中期业绩兑现后板块回调压力延续
【券商聚焦】交银国际:医药行业收入稳健增长 多重利好推动盈利表现显著改善
金吾财讯 · 09-04
【券商聚焦】交银国际:医药行业收入稳健增长 多重利好推动盈利表现显著改善
药明生物(02269.HK)根据首次公开发售前购股权计划合共发行242.39万股
智通财经 · 09-03
药明生物(02269.HK)根据首次公开发售前购股权计划合共发行242.39万股
药明生物新增发行2,423,900股并多次回购累计39,824,500股
公告速递 · 09-03
药明生物新增发行2,423,900股并多次回购累计39,824,500股
北水动向|北水成交净买入33.95亿 北水加仓大模型概念及光通信板块 继续抛售阿里巴巴(09988)
智通财经 · 09-03
北水动向|北水成交净买入33.95亿 北水加仓大模型概念及光通信板块 继续抛售阿里巴巴(09988)
【生物医药小白投研】第八篇:小白完整投研框架与体系复盘
港股解码 · 09-03
【生物医药小白投研】第八篇:小白完整投研框架与体系复盘
加载更多
公司概况
公司名称:
药明生物
所属市场:
SEHK
上市日期:
--
主营业务:
药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联(XDC)分部主要从事为抗体偶联药物(ADCs)及各种生物偶联药物提供合同研究、开发及生产组织(CRDMO)服务。该公司主要在国内和国外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":49.22,"timestamp":1789459709004,"preClose":49.14,"halted":0,"volume":24349729,"delay":0,"changeRate":0.0016280016280015932,"floatShares":4156000000,"shares":4156000000,"eps":1.3563613543827169,"marketStatus":"已收盘","change":0.08,"latestTime":"09-15 16:08:29","open":49.14,"high":49.5,"low":48.2,"amount":1194064577,"amplitude":0.026455,"askPrice":49.22,"askSize":103000,"bidPrice":49.2,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":1.3841491597373663,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789522200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":49.14,"openAndCloseTimeList":[[1789435800000,1789444800000],[1789448400000,1789459200000]],"volumeRatio":0.899136,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.481,"impliedVolPercentile":0.4082},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2667763172","title":"港股异动 | CRO概念股涨幅居前、凯莱英大涨12%,中报持续验证行业高景气,多家公司上调业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2667763172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667763172?lang=zh_cn&edition=full","pubTime":"2026-09-14 13:34","pubTimestamp":1789364090,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,CRO概念股涨幅居前,截至发稿,凯莱英涨5.89%,报142.1港元;康龙化成涨4.72%,报28.84港元;泰格医药涨4.64%,报43.32港元;药明生物涨2.30%,报48.08港元。消息面上,国内外CXO公司中报业绩持续验证行业高景气。国内药明康德发布中报,业绩大幅超市场预期,同时大幅上调全年业绩指引。该行表示,看好药明系、康龙化成、凯莱英、泰格医药及金斯瑞。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495468.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | CRO概念股涨幅居前,中报持续验证行业高景气,多家公司上调业绩指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0359201612.USD","03347","LU0326950275.SGD","02269","LU0456827905.SGD","SG9999002463.SGD","LU0051755006.USD","LU0348735423.USD","LU0588546209.SGD","LU1720050803.USD","LU2039709279.SGD","BK1141","06821","LU0456846285.SGD","LU0348827113.USD","LU0359202008.SGD","LU0561508036.HKD","LU0128526141.USD","KURE","03759","LU0327786744.USD","BK4588","LU0823426480.USD","LU0516423174.USD","LU0181495838.USD","LU0417516738.SGD","LU0348825331.USD","LU0029874061.USD","LU0819121731.USD","LU0572944931.SGD","LU1880383366.USD","BK1583","LU0039217434.USD","BK1191","KCAI","BK1610","VXUS","LU0516422952.EUR","LU0307460666.USD","BK1521","BK1589","LU0856984785.SGD","LU1688375341.USD","LU0516423091.SGD","LU0140636845.USD","LU0979878070.USD","LU3063872942.SGD","LU0320764599.SGD","LU0516422366.SGD","LU0823426308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667378766","title":"港股早盘低开高走 恒生指数半日上涨0.35% 药明生物(02269)涨4.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667378766","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667378766?lang=zh_cn&edition=full","pubTime":"2026-09-14 12:18","pubTimestamp":1789359482,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘低开高走,截至午间收盘,恒生指数上涨0.35%;国企指数上涨0.4%,恒生科技指数上涨0.17%。医药概念板块表现强势,凯莱英涨10.88%,康龙化成涨5.15%,泰格医药涨7%,药明康德涨4.61%,药明生物涨4.81%。个股方面,联想集团股价扬升,半日涨4.6%。在中国x86服务器市场,第二季度,联想的x86服务器营收同比增长9.0%,以10.5%的市场份额排名第四。长风药业股价冲高回落,半日涨1.16%。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991494","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["83115","LU0516423174.USD","LU0456827905.SGD","LU0264606111.USD","LU0516422440.USD","LU0052750758.USD","LU0051755006.USD","IE00B0JY6N72.USD","SG9999002463.SGD","LU0417516902.SGD","LU1720050803.USD","LU0128522157.USD","BK1610","02652","LU0417516738.SGD","LU0043850808.USD","LU0890818403.SGD","HK0000320223.HKD","LU0327786744.USD","BK1141","LU0516422952.EUR","LU0320764755.SGD","LU1242518931.SGD","IE0003895053.USD","LU1235295612.USD","LU0359202008.SGD","LU0456846285.SGD","LU1242518857.USD","SG9999002562.SGD","LU1366334651.USD","LU1808992512.USD","LU0708995583.HKD","LU0310800965.SGD","LU1794554557.SGD","07200","02269","BK1521","03115","LU0359201612.USD","LU0862451753.SGD","02833","KURE","LU0052756011.USD","LU0348827113.USD","LU0823426480.USD","IE0034224299.USD","LU1267930227.SGD","80992","MCHmain","LU0588546209.SGD","LU1785774172.SGD","LU0128526141.USD","LU0791590937.USD","BK1526","LU0326950275.SGD","LU0561508036.HKD","LU0819121731.USD","03419","LU0856984785.SGD","LU0862451837.USD","LU0791591158.USD","07300","LU0672654166.SGD","09115","LU0039217434.USD","HHImain","02800","LNVGY","HK0000306685.HKD","LU0140636845.USD","LU0348825331.USD","LU0543330483.HKD","LU3063872942.SGD","00992","LU1366334578.USD","LU0979878070.USD","BK1191","LU0370786039.SGD","BK1589","LU1880383366.USD","513600","HK0000320264.USD","LU0972618739.USD","03037","LU0128525689.USD","LU0320764599.SGD","LU0516422366.SGD","LU0348735423.USD","07500","WXXWY","LU0572940350.SGD","TCHI","LU0049112450.USD","LU1046422090.SGD","LU2039709279.SGD","LU0048580855.USD","HSI","LU0572939691.SGD","82800","HSTECH","IE0032431581.USD","LU0307460666.USD","BK1193","LU0823426308.USD","BK1576","LU2242644610.SGD","BK1607","LU0181495838.USD","LU0516423091.SGD","LU1688375341.USD","LU0572944931.SGD","LU0029875118.USD","HK0000306701.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198560754","title":"异动解读|药明生物盘中上涨3.06%,CXO板块集体走强带动反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1198560754","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198560754?lang=zh_cn&edition=full","pubTime":"2026-09-14 10:27","pubTimestamp":1789352861,"startTime":"0","endTime":"0","summary":"9月14日,药明生物盘中上涨3.06%,报48.44港元/股,成交额3.45亿港元。同日生命科学工具和服务板块集体走强,康龙化成涨5.74%,药明康德涨3.23%,金斯瑞生物科技涨2.35%。消息面上,近期CXO及创新药板块迎来估值修复行情,多家券商确认板块底部特征,\"药明系\"企业此前推出合计最高约55亿元回购计划对股价形成提振。公司层面,上半年收益117.87亿元,同比增长18.4%,经调整归母净利同比增长38.4%,全年业绩指引上调;未完成订单约55亿美元,同比增长约30%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物盘中走强,CXO板块集体反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667083631","title":"医药板块表现强势 凯莱英(06821)涨超5% 机构制AI制药商业化风口初步显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2667083631","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667083631?lang=zh_cn&edition=full","pubTime":"2026-09-14 10:26","pubTimestamp":1789352818,"startTime":"0","endTime":"0","summary":"消息面上,招商证券指出,自2024年以来,AI制药发展速度明显加快,投资规模和项目数量显著增长。跨国药企开始大规模搭建自有AI平台能力,合作模式由单点项目合作转向管线与平台层面深度合作。AI科技巨头入局药物研发领域,依托通用大模型推出面向药物研发的专用AI模型。AI Biotech的合作机会与交易规模持续扩容,即便尚未拥有成熟商业化管线,也获得传统药企青睐。AI制药行业已完成概念验证,正式迈入临床验证阶段,商业化风口初步显现。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991473","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","03759","LU0043850808.USD","BK1141","CHAT","KURE","LU1242518931.SGD","LU0417516902.SGD","LU2125910500.SGD","02269","AIPO","VTHR","09939","LU0516422366.SGD","LU1880383366.USD","IE00B0JY6N72.USD","BK1191","01477","BK1583","LU1720050803.USD","QTOC","LU0516422440.USD","LU0516423174.USD","LU1688375341.USD","LU0128526141.USD","LU0819121731.USD","LU0588546209.SGD","02359","002821","SG9999002463.SGD","06821","ARTY","LU1046422090.SGD","AGIX","LU0326950275.SGD","159938","LU0979878070.USD","SG9999002562.SGD","LU2242644610.SGD","LU0348766576.USD","LU0823426480.USD","LU0359201612.USD","LU0417516738.SGD","LU1242518857.USD","BK1515","03347","LU0052750758.USD","BK0239","LU0307460666.USD","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667778631","title":"港股异动 | CRO概念股涨幅居前 中报持续验证行业高景气 多家公司上调业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2667778631","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667778631?lang=zh_cn&edition=full","pubTime":"2026-09-14 10:23","pubTimestamp":1789352605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0516422366.SGD","BK1521","SG9999002463.SGD","06821","03759","LU1720050803.USD","BK1576","LU0359201612.USD","BK1191","LU0307460666.USD","LU0348827113.USD","LU0043850808.USD","LU0359202008.SGD","LU0819121731.USD","LU0417516738.SGD","BK1589","LU0516423091.SGD","BK1141","LU0708995583.HKD","LU0561508036.HKD","BK1583","LU2039709279.SGD","LU0128526141.USD","03347","LU1880383366.USD","LU0856984785.SGD","LU0140636845.USD","02269","LU0979878070.USD","LU0823426480.USD","LU1688375341.USD","LU0516423174.USD","LU0348825331.USD","LU0029874061.USD","LU0572944931.SGD","KURE","IE00B0JY6N72.USD","LU0052750758.USD","LU0320764599.SGD","BK1610","LU0456846285.SGD","LU1242518857.USD","LU0516422440.USD","SG9999002562.SGD","LU1794554557.SGD","LU0588546209.SGD","LU0181495838.USD","LU0456827905.SGD","LU0348735423.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171381892","title":"异动解读|药明生物盘中下跌3.07%,报47.38港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171381892","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171381892?lang=zh_cn&edition=full","pubTime":"2026-09-10 11:01","pubTimestamp":1789009288,"startTime":"0","endTime":"0","summary":"9月10日,药明生物盘中下跌3.07%,报47.38港元/股,成交额5.16亿港元。药明生物所在的生命科学工具和服务行业整体走弱,个股中,英矽智能跌0.75%,金斯瑞生物科技跌3.21%,药明康德跌0.78%,药明合联跌1.75%,晶泰控股跌0.55%。药明生物是一家主要从事向生物制剂行业客户提供生物发现、开发及生产端到端解决方案及服务的投资控股公司,业务涵盖生物药及XDC两大分部,在国内和国外市场开展业务。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666128556","title":"【券商聚焦】中信证券:中国创新药进入全球价值兑现阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2666128556","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666128556?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:59","pubTimestamp":1789001960,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指,2026年以来,中国创新药国内市场快速放量,从中报来看头部创新药企业在新产品驱动下,创新药收入快速增长,biopharma陆续进入盈利拐点;出海创新药开始进入三期/注册研究兑现阶段;近期多个国际学术大会将至,众多创新药管线进入密集的数据催化期。该机构认为中国创新药进入全球价值兑现阶段,建议关注:①头部国际化创新药企业有望迎来产品全球价值兑现期;②头部创新药企业产品放量进入新的成长阶段;③具有全球潜力的管线资产国际化有望加速兑现。综上,我们维持创新药行业“强于大市”评级。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991210","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","LU0348825331.USD","LU1820825898.SGD","LU1969619763.USD","LU0348783233.USD","LU1997245177.USD","KURE","LU1226287875.USD","09995","LU1794554557.SGD","LU1580142542.USD","LU1720050803.USD","LU2148510915.USD","01801","06160","BK0028","LU1064130708.USD","LU0516422952.EUR","LU0463099449.HKD","LU1655091616.SGD","LU0979878070.USD","LU0417516738.SGD","LU0181495838.USD","LU0572944931.SGD","LU1813983027.USD","LU1961090484.USD","LU2039709279.SGD","09926","02142","LU1255011170.USD","600030","LU0405327494.USD","01093","IE0008369823.USD","09688","06030","01877","LU0561508036.HKD","LU1880383366.USD","KCE","LU1226287792.SGD","LU0819121731.USD","BK1161","01177","IE00B543WZ88.USD","LU2580892862.HKD","SG9999004220.SGD","BK1141","02616","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165341452","title":"药明生物:9月9日发行120万股并多次回购股份累计约3,982.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1165341452","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165341452?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:42","pubTimestamp":1788961372,"startTime":"0","endTime":"0","summary":"2026年9月9日,药明生物发布翌日披露报表,宣布于当日根据2016年1月5日采纳并于2016年8月10日修订的首次公开发售前购股权计划,因董事行使期权,按每股2.64港元发行120万股普通股,占截至2026年9月7日公司已发行股份约0.02888%。本次发行后,公司已发行股本增至4,155,933,877股。此外,公司自2026年5月27日至7月7日期间,于香港联交所场内多次回购合计3,982.45万股,回购股数占当时已发行股本的日均比重介乎0.03486%至0.15734%,每股回购价格介乎每股29.46港元至36.75港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物:9月9日发行120万股并多次回购股份累计约3,982.45万股","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666653665","title":"药明生物(02269.HK)因期权获行使而发行120万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666653665","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666653665?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:40","pubTimestamp":1788961206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1521","LU0588546209.SGD","LU1242518931.SGD","LU0128526141.USD","LU1794554557.SGD","LU2039709279.SGD","LU1688375341.USD","BK1141","LU1880383366.USD","LU0417516738.SGD","SG9999002562.SGD","LU0823426308.USD","LU0326950275.SGD","LU0348735423.USD","LU0708995583.HKD","LU0979878070.USD","LU0572944931.SGD","LU3063872942.SGD","LU0516423174.USD","LU0039217434.USD","LU0359201612.USD","SG9999002463.SGD","LU0516423091.SGD","LU0359202008.SGD","LU0417516902.SGD","LU0043850808.USD","LU1242518857.USD","LU0516422952.EUR","LU0051755006.USD","LU0348825331.USD","LU0823426480.USD","02269","LU0819121731.USD","LU1720050803.USD","LU0456846285.SGD","LU0140636845.USD","LU0516422440.USD","LU0029874061.USD","IE00B0JY6N72.USD","LU0456827905.SGD","LU0181495838.USD","BK1610","LU0320764599.SGD","LU0856984785.SGD","KURE","BK1589","BK1576","LU0516422366.SGD","LU0307460666.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118201250","title":"创胜集团医药-B授予药明生物Hicb平台及Excelpro细胞培养基非独家许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1118201250","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118201250?lang=zh_cn&edition=full","pubTime":"2026-09-09 20:02","pubTimestamp":1788955330,"startTime":"0","endTime":"0","summary":"创胜集团医药-B(TRANSCENTA-B)宣布,已向药明生物(WUXI BIO)授予其Hicb平台及Excelpro细胞培养基的非独家许可。\n这一举措标志着两家生物医药企业之间的深度合作。通过该协议,药明生物将获得使用创胜集团先进的Hicb抗体发现平台和高效的Excelpro细胞培养基技术的权限。\n值得注意的是,非独家授权的形式允许创胜集团未来继续向其他合作伙伴提供相同技术,而药明生物则能借此增强其研发和生产能力。业界观察人士认为,此类技术共享有助于加速生物制剂的开发进程,并可能对行业竞争格局产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0140636845.USD","LU1242518857.USD","BK1589","LU0359202008.SGD","IE00B0JY6N72.USD","LU1688375341.USD","LU2039709279.SGD","LU0181495838.USD","LU0588546209.SGD","BK1161","LU0051755006.USD","LU0052750758.USD","LU0819121731.USD","LU0856984785.SGD","LU0417516738.SGD","LU0979878070.USD","LU0320764599.SGD","KURE","LU0039217434.USD","LU0348735423.USD","02269","LU0359201612.USD","LU0708995583.HKD","LU1880383366.USD","SG9999002562.SGD","LU0348825331.USD","06628","LU0456846285.SGD","LU0516422952.EUR","LU1242518931.SGD","LU0516422366.SGD","LU0029874061.USD","LU0043850808.USD","LU0572944931.SGD","BK1141","LU0128526141.USD","LU3063872942.SGD","LU0327786744.USD","LU0516423174.USD","LU1720050803.USD","LU0456827905.SGD","BK1610","LU0417516902.SGD","LU0516422440.USD","LU0516423091.SGD","LU0307460666.USD","LU0823426480.USD","SG9999002463.SGD","LU0326950275.SGD","LU0823426308.USD","BK1521","LU1794554557.SGD","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665341019","title":"商务部新增84个全国重点外资项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341019","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665341019?lang=zh_cn&edition=full","pubTime":"2026-09-08 12:05","pubTimestamp":1788840300,"startTime":"0","endTime":"0","summary":"【大河财立方记者程帅星厦门报道】9月8日,大河财立方记者在第二十六届中国国际投资贸易洽谈会(以下简称“投洽会”)上获悉,商务部近日新增84个全国重点外资项目,其中包括6个外资标志性项 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU2756315318.SGD","LU2168563687.JPY","SKHZ","LU1989771016.USD","LU0158827781.USD","LU2328871848.SGD","LU2168564065.EUR","LU1093756325.SGD","LU2462591350.SGD","LU2471134523.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU1023059063.AUD","IE00BWXC8680.SGD","LU2471134796.USD","LU0097036916.USD","CURE","LU0964807845.USD","SKHY","SKHN","BK0188","LU2089283258.USD","LU2360106947.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU0823426480.USD","SGXZ31699556.SGD","LU0823397103.USD","LU1974910355.USD","LU1323610961.USD","LU0979878070.USD","LU2265009873.SGD","LU0058720904.USD","SG9999015986.USD","LU0516422366.SGD","BK1589","LU2361044949.HKD","LU1794554557.SGD","LU2236285917.USD","VHT","LU2461242641.AUD","LU0823413587.USD","LU2552382215.SGD","IE00B775H168.HKD","LU2750360997.AUD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2111349929.HKD","BK0028","LU0823416689.USD","SGXZ99366536.SGD","IE00B1XK9C88.USD","LU0353189763.USD","LU0122379950.USD","LU1868837136.USD","LU2237443465.HKD","LU1280957306.USD","LU0689472784.USD","LU0096364046.USD","LU2491049909.HKD","LU0456855351.SGD","SKUU","LU0354030438.USD","IE0004445015.USD","LU2746668461.USD","LU0787776722.HKD","LU0466842654.USD","LU1629891620.HKD","LU2213496289.HKD","IE0001KFT4U8.USD","SG9999018857.SGD","SG9999014898.SGD","LU0327786744.USD","LU0823413660.USD","RXL","SG9999001176.SGD","LU0052750758.USD","SGXZ81514606.USD","AGNG","LU0516422440.USD","GDOC","LU2168564222.USD","LU0856984785.SGD","LU0114720955.EUR","LU2750360641.GBP","LU0708995401.HKD","LU0234572021.USD","LU0348825331.USD","LU1814569148.SGD","SG9999002463.SGD","LU1983299246.USD","SKHYV","IHE","LU0823434583.USD","LU2237438978.USD","LU2237443978.SGD","LU2271345857.HKD","LU1988902786.USD","LU0051755006.USD","LU0109394709.USD","LU2746668974.SGD","IE00BK4W5L77.USD","LU0326950275.SGD","MEDI","LU2357305700.SGD","LU0471298777.SGD","SG9999015978.USD","BK0208","LU0079474960.USD","LU3063872942.SGD","LU1691799644.USD","WDNA","LU2471134879.HKD","LU0029864427.USD","LU0203201768.USD","BK4568","HRTS","LU0128526141.USD","LU1969619763.USD","SKHA","LU2324357040.USD","IE00BJLML261.HKD","MHIP","LU0006306889.USD","LU1069344957.HKD","LU1880383366.USD","IE00B2B36J28.USD","LU1242518931.SGD","LU1720050803.USD","LU0819121731.USD","LU0348735423.USD","LU1868836757.USD","LU0882574139.USD","IYH","BK4533","BK4599","LU2063271972.USD","PPH","LU0029874061.USD","LU2089284900.SGD","LU1868837300.USD","SG9999017495.SGD","LU2211815571.USD","LU0174119429.USD","LU2361044865.SGD","LU1548497426.USD","ILDR","LU0359202008.SGD","LU0225283273.USD","LU2756315664.SGD","LU2468319806.SGD","LU2168564149.EUR","LU1551013425.SGD","LU2417539215.USD","IE00B4R5TH58.HKD","LU2462157665.USD","LU1688375341.USD","SG9999015952.SGD","LU0572944931.SGD","LU0640476718.USD","SGXZ57979304.SGD","SG9999018865.SGD","LU0203202063.USD","LU0256863811.USD","LU0516422952.EUR","LU0823426308.USD","LU1868836591.USD","LU0417516738.SGD","LU2552382058.USD","LU1035775433.USD","IE00B7KXQ091.USD","LU2106854487.HKD","BK0197","LU0198837287.USD","SG9999002562.SGD","LU0238689110.USD","LU2023250330.USD","LU2237443382.USD","LU1242518857.USD","LU1145028129.USD","TMED","IE00B1BXHZ80.USD","BK4581","LU0181495838.USD","MEDX","LLII","TRUH","LLYX","BK1521","LU0516423174.USD","LU1551013342.USD","IE00B3T34201.USD","LU2602419157.SGD","LU2108987350.USD","LU1291159041.SGD","LU2491050154.USD","LU0345770308.USD","LU0359201612.USD","LU1868836914.USD","LU1720051017.SGD","LU2028103732.USD","LU2552382132.HKD","LU0266013472.USD","LU2491050071.SGD","SG9999014880.SGD","LU2023251221.USD","LU2237443549.SGD","LU1979441026.SGD","LU2087625088.SGD","KURE","LU0289739699.SGD","LU0133085943.USD","LU2039709279.SGD","LU0943347566.SGD","LU1366192091.USD","LU0316494557.USD","LU1956131251.USD","LU0820561909.HKD","LU0210536198.USD","BK4585","IE0009355771.USD","LU1917777945.USD","IE0004445239.USD","BK4141","02269","IE0005OL40V9.USD","IE00BJJMRY28.SGD","BK1576","LU0823434740.USD","LU0385154629.USD","LU2168564495.EUR","LU0106261372.USD","LU1829250122.USD","IE00BKPKM429.USD","LU0417517546.SGD","PJP","IE00BJJMRX11.SGD","LU0889565916.HKD","LU2471134952.CNY","SG9999013999.USD","LU1232071149.USD","LU0310800379.SGD","SKHQ","BK1141","LU0471298694.HKD","LU0323591593.USD","IE00BJJMRZ35.SGD","THNR","LU0786609619.USD","SKHU","07709","SKHL","LLY","LU2896262040.SGD","LU0320765992.SGD","LU0158827948.USD","LU1127390331.HKD","IE0002141913.USD","LU0109391861.USD","BK4007","LU1057294990.SGD","LU0820561818.USD","AZNH","IE00BN29S564.USD","ELIL","LU2456880835.USD","OZEM","LU0039217434.USD","SKDD","FTXH","LU0672654240.SGD","WXXWY","LU0516423091.SGD","GB00BDT5M118.USD","BK4534","LU0456846285.SGD","LU0432979614.USD","LU1064131342.USD","LU0353189680.USD","LU2237443895.HKD","LU0708994859.HKD","LU0320765059.SGD","LU0820562030.AUD","LU2023250504.SGD","AZN","LU1267930573.SGD","JDOC","LU0354030511.USD","IE00BKDWB100.SGD","ABB","LU2237443622.USD","LU0588546209.SGD","LU0140636845.USD","HYNX","IE00BFSS7M15.SGD","LU0456827905.SGD","XLV","SG9999014914.USD","LU1093756168.USD","LU0094547139.USD","BK4096","SKHX","LU0683600562.USD","IXJ","LU1061106388.HKD","LU2089984988.USD","LU2361045086.USD","IE00BFSS8Q28.SGD","LU0708995583.HKD","BK0196","SGXZ51526630.SGD","LU1804176565.USD","LU1623119135.USD","LU0128525929.USD","LU0320764599.SGD","LU0307460666.USD","CANC","SK","SG9999014906.USD","BK4588","ELIS","BK4516","LU1712237335.SGD","SG9999015945.SGD","LU0823397285.USD","LU2112291526.USD","LU0417516902.SGD","LLYZ","BK1610","FHLC","LU1720051108.HKD","IE00BK4W5M84.HKD","BK0187","LU0256863902.USD","LU0345770993.USD","LU0882574055.USD","LU0043850808.USD","IE00B0JY6N72.USD","002493","LU1267930730.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106512590","title":"药明生物自5月27日至7月7日回购3,982.45万股,涉资约12.72亿港元,并于9月7日发行180.41万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1106512590","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106512590?lang=zh_cn&edition=full","pubTime":"2026-09-07 20:57","pubTimestamp":1788785863,"startTime":"0","endTime":"0","summary":"9月7日,药明生物发布翌日披露报表。公告显示,公司自2026年5月27日至2026年7月7日期间,累计回购39,824,500股,占当时已发行股本相应百分比区间介乎0.03488%至0.15741%,回购价格介乎每股29.46港元至36.75港元,累计涉及总金额约12.72亿港元。上述回购股份尚未注销。本次发行完成后,公司于2026年9月7日的已发行股本增至4,154,733,877股。公司在公告中确认,已严格遵守香港联交所证券上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物自5月27日至7月7日回购3,982.45万股,涉资约12.72亿港元,并于9月7日发行180.41万股","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184934047","title":"药明生物9月4日增发320万股并累计回购3982.45万股,耗资约12.72亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184934047","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184934047?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:02","pubTimestamp":1788523362,"startTime":"0","endTime":"0","summary":"药明生物于2026年9月4日发布翌日披露报表。公告显示,公司于当日根据2016年1月5日采纳的首次公开发售前购股权计划,因董事行使期权,发行了普通股320万股,每股发行价为2.64港元,合计约0.08亿港元,占发行前现有已发行股份约0.07711%。本次增发后,公司已发行股份总数由4,149,729,787股增至4,152,929,787股。此外,公司自2026年5月27日至2026年7月7日期间累计回购了39,824,500股,约占截至回购首日前公司已发行股本的0.96%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物9月4日增发320万股并累计回购3982.45万股,耗资约12.72亿港元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2664433182","title":"药明生物(02269)因期权获行使而发行320万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664433182","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664433182?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:59","pubTimestamp":1788523143,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明生物(02269)发布公告,根据公司于2016年1月5日采纳的首次公开发售前购股权计划(于2016年8月10日修订)为行使期权而发行320万股普通股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492301.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物(02269)因期权获行使而发行320万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0327786744.USD","LU0359201612.USD","LU0326950275.SGD","LU1720050803.USD","LU0572944931.SGD","02269","LU2039709279.SGD","LU1242518857.USD","LU0029874061.USD","LU1688375341.USD","LU0307460666.USD","LU0039217434.USD","BK1576","LU0128526141.USD","LU1794554557.SGD","LU0979878070.USD","BK1141","LU1880383366.USD","LU0140636845.USD","LU0588546209.SGD","LU0181495838.USD","LU0516422440.USD","BK1589","LU0417516738.SGD","LU1242518931.SGD","LU0348825331.USD","LU0348735423.USD","BK1610","LU0516422366.SGD","LU0320764599.SGD","LU0456846285.SGD","BK1521","LU0516423091.SGD","LU0359202008.SGD","LU0856984785.SGD","LU0052750758.USD","LU0708995583.HKD","LU0819121731.USD","LU0456827905.SGD","KURE","SG9999002463.SGD","SG9999002562.SGD","LU0417516902.SGD","LU0823426480.USD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0043850808.USD","LU0051755006.USD","LU0516422952.EUR","LU0823426308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196143188","title":"异动解读|药明生物盘中下跌3.12%,中期业绩兑现后板块回调压力延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1196143188","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196143188?lang=zh_cn&edition=full","pubTime":"2026-09-04 14:29","pubTimestamp":1788503393,"startTime":"0","endTime":"0","summary":"9月4日,药明生物盘中下跌3.12%,报49.12港元,成交额14.31亿港元,此前一个交易日因大手笔回购消息短暂反弹近3%后再度走弱。消息面上,公司8月25日披露的强劲中期业绩及多家投行上调目标价至57-61港元的利好已在前期股价中充分消化,此前累计回购约3982万股涉资逾12.72亿港元的提振效应亦趋减弱,获利回吐压力持续释放。同业金斯瑞生物科技大跌11.4%、药明康德跌0.52%,CXO板块整体承压,进一步拖累市场情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"药明生物再度走弱,CXO板块承压回调","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238859","title":"【券商聚焦】交银国际:医药行业收入稳健增长 多重利好推动盈利表现显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238859","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664238859?lang=zh_cn&edition=full","pubTime":"2026-09-04 09:00","pubTimestamp":1788483634,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示,1H26港股/A股医药行业整体收入增长4.7%/3.2%。创新药产业链增速领跑行业,服务板块复苏:1)港股/A股CXO收入整体增长29.2%/25.3%,(扣非)净利润增长23.4%/67.6%,在各子板块中增速最快,行业整体景气度和订单需求处于高位。2)核心成药板块收入增长17.8%/3.4%、利润增长62.7%/35.0%。其中生物药增速远超化药,在板块收入中的占比也进一步提升。3)医院、器械、诊断、疫苗等板块业绩有复苏趋势。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990646","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","01951","02596","02096","03329","06078","LU0315179316.USD","LU1152091168.USD","LU2543165471.USD","BK1515","01530","01801","LU0856984785.SGD","LU1880383366.USD","IE00B0JY6N72.USD","03692","03759","06990","BK1209","00013","02269","09966","LU1251922891.USD","IE00B543WZ88.USD","01952","09996","HK0000320264.USD","LU0327786744.USD","01276","06996","BK1589","IE00B5MMRT66.SGD","02273","LU0307460666.USD","LU0348783233.USD","01093","KURE","KCE","LU0039217434.USD","LU0588546209.SGD","01177","06160","SG9999004220.SGD","01548","09926","BK1161","02162","02268","LU1242518857.USD","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870047","title":"药明生物(02269.HK)根据首次公开发售前购股权计划合共发行242.39万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870047","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664870047?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:34","pubTimestamp":1788446092,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0516422366.SGD","LU0456827905.SGD","BK1589","LU0327786744.USD","LU0140636845.USD","LU0516422952.EUR","LU1880383366.USD","LU0039217434.USD","LU0051755006.USD","LU0052750758.USD","BK1521","LU3063872942.SGD","LU0029874061.USD","LU0856984785.SGD","LU0516423091.SGD","LU0320764599.SGD","IE00B0JY6N72.USD","LU1720050803.USD","LU0417516738.SGD","LU1242518931.SGD","LU0181495838.USD","LU0417516902.SGD","LU0823426308.USD","SG9999002463.SGD","LU0348825331.USD","LU0128526141.USD","LU1688375341.USD","LU0979878070.USD","BK1610","BK1576","LU0516423174.USD","LU0588546209.SGD","LU0572944931.SGD","LU0516422440.USD","LU0043850808.USD","02269","LU0823426480.USD","LU0456846285.SGD","LU0359202008.SGD","LU2039709279.SGD","LU0708995583.HKD","SG9999002562.SGD","LU0359201612.USD","LU0348735423.USD","LU0819121731.USD","LU0326950275.SGD","KURE","LU1242518857.USD","LU0307460666.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155797229","title":"药明生物新增发行2,423,900股并多次回购累计39,824,500股","url":"https://stock-news.laohu8.com/highlight/detail?id=1155797229","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155797229?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:27","pubTimestamp":1788445626,"startTime":"0","endTime":"0","summary":"药明生物于2026年9月3日公布翌日披露报表。公司在2026年9月3日,分别因根据2016年1月5日的首次公开发售前购股权计划行使期权,向公司董事及其他参与人合计发行2,423,900股新股,发行价分别为每股港币2.76元及港币2.64元,约占发行前已发行股本的0.05845%。本次发行完成后,公司已发行股本增至4,149,729,787股。回购价格区间介乎每股港币29.46元至港币36.75元,按交易量加权平均计算,总体回购均价约每股港币31.93元,涉资合计约12.72亿港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物新增发行2,423,900股并多次回购累计39,824,500股","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873279","title":"北水动向|北水成交净买入33.95亿 北水加仓大模型概念及光通信板块 继续抛售阿里巴巴(09988)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873279","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664873279?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:51","pubTimestamp":1788429116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,9月3日港股市场,北水成交净买入33.95亿港元。其中港股通(沪)成交净买入6.98亿港元,港股通(深)成交净买入26.97亿港元。9月1日,小米汽车公布8月交付数据,单月交付量再次突破30000台。阿里巴巴-W遭净卖出7.6亿港元。阿里巴巴此前宣布配售新股,配售总金额为800亿港元。这是阿里巴巴自2019年港股上市以来首次启动新股配售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0164880469.USD","LU0231483743.USD","LU1211504680.USD","LU1102505929.USD","LU2097828474.EUR","LU1171460220.USD","LU0029874061.USD","LU1688375341.USD","BK1502","WXXWY","LU0269904917.USD","LU0509642566.USD","LU1439103000.SGD","IE00BQXX3C00.GBP","LU0499858602.USD","LU0117844026.USD","LU1064131003.USD","LU0502904849.HKD","LU1734074674.USD","SG9999000418.SGD","LU0605514214.HKD","LU0417516902.SGD","LU0672654166.SGD","LU0828237510.HKD","LU0315179316.USD","LU2279701549.SGD","LU0128526141.USD","BK1141","LU1226288097.SGD","IE0009570106.USD","LU0264606111.USD","LU0149721374.USD","LU0651946864.USD","LU2045819591.USD","81810","LU1993786604.SGD","LU1366334578.USD","BK1506","LU1807302812.USD","LU0084288322.USD","LU1883866441.USD","LU1044876610.USD","LU2237443549.SGD","LU0043850808.USD","LU2294711473.HKD","HK0000286598.CNH","07226","LU1328615791.USD","03417","LU2097829019.USD","ODDS","LU0235996351.USD","SG9999015986.USD","IE0032431581.USD","LU0210533765.USD","IE0008368304.USD","LU0188438112.USD","LU0039217434.USD","HK0001040168.HKD","LU0128522744.USD","SG9999002828.SGD","LU2187417386.USD","LU1733274473.HKD","LU0823413587.USD","LU0359201885.HKD","LU0210526637.USD","LU0414403682.SGD","LU1808992512.USD","BK1163","LU2362540622.SGD","89988","LU0254981946.USD","IE00BQXX3D17.EUR","LU0577902371.SGD","07552","LU1917777945.USD","LU0819121731.USD","LU0067412154.USD","LU1770036033.HKD","LU0326950275.SGD","BK1533","LU0169518387.USD","SG9999002562.SGD","LU0648000940.SGD","LU0293314216.USD","LU2362541273.HKD","IE00BZ08YT58.USD","LU1813983027.USD","LU0197773160.USD","LU0348816934.USD","LU1048588211.SGD","SG9999007991.SGD","LU0985320562.USD","BK1149","LU1196710351.USD","IE0008368742.USD","LU0630378429.USD","LU3227948356.SGD","LU0164872284.USD","BK1607","LU0856984785.SGD","LU0314109678.HKD","LU0823413660.USD","00148","LU0320764599.SGD","HK0000107257.USD","IE0001KFT4U8.USD","LU1960683339.HKD","LU0589944569.HKD","BK1122","LU1981816686.USD","SGXZ86797644.SGD","LU0979878070.USD","LU1655091616.SGD","LU1720051017.SGD","LU0823041008.USD","LU1048596156.SGD","LU2125910849.SGD","LU2357305700.SGD","LU0608807946.USD","LU0054450605.USD","LU0054237671.USD","BK1610","LU1102505762.USD","LU1880398471.USD","LU1880383440.USD","LU0181495838.USD","LU0865486749.SGD","LU1152091754.HKD","LU3063872942.SGD","SG9999000327.SGD","SGXZ81514606.USD","LU0274383008.USD","LU0128522157.USD","LU0287142896.SGD","LU0708995153.HKD","LU0862451753.SGD","LU0244354667.USD","IE0003851619.USD","LU1769817179.HKD","SG9999018857.SGD","LU1814569148.SGD","LU1226288253.USD","LU0738912210.USD","LU0862451837.USD","LU0051755006.USD","LU0127658192.USD","SG9999003461.SGD","SG9999006514.SGD","LU1810669033.SGD","SG9999014880.SGD","LU0737861772.HKD","LU0315178854.USD","LU2023250504.SGD","LU0320764243.SGD","00981","LU0918141887.USD","LU0828238088.HKD","LU1051768304.USD","LU0708995583.HKD","LU0061477393.USD","IE00B8L5B284.USD","BK1095","SG9999017495.SGD","BK1501","LU0348783233.USD","JEMA","LU2251237306.USD","LU2351347302.SGD","LU0516422440.USD","BK1526","SG9999018865.SGD","LU0516422952.EUR","LU0543330483.HKD","LU0047713382.USD","LU0516422366.SGD","LU0972618739.USD","LU0886674414.USD","LU2293587155.HKD","LU0348814723.USD","SG9999014906.USD","HK0000352291.HKD","LU0164865239.USD","LU0348788117.USD","LU0784639295.USD","SGXZ62798434.SGD","BK1142","LU2106854487.HKD","LU0228367735.SGD","LU0577902454.USD","LU0828237940.HKD","LU2498475776.HKD","LU0456842615.SGD","LU0329678337.USD","LU0441854154.USD","HK0000914660.USD","LU0823426308.USD","SG9999014914.USD","LU0607220059.USD","BK1609","LU0737861699.HKD","LU2449936058.SGD","KBDCY","LU0229945570.USD","BK1618","LU0463099449.HKD","BK1615","09088","LU0572944931.SGD","LU0384037296.USD","LU1366334651.USD","HK0000165453.HKD","LU0588545490.SGD","LU0096374516.USD","LU0259732245.USD","LU0821914370.USD","LU0149534421.HKD","LU0648948544.HKD","03032","LU1196710864.SGD","HK0000352382.USD","LU0132412106.USD","LU0140636845.USD","BABA","LU1226287529.USD","LU2237443895.HKD","LU0531970944.HKD","HK0000288784.HKD","SG9999001226.SGD","SG9999015952.SGD","SG9999001689.USD","SGXZ31699556.SGD","LU1504937902.USD","LU1481107354.HKD","IE00BMPRXN33.USD","LU2265009873.SGD","IE0032834883.USD","LU0029875118.USD","BKF","LU1282649810.SGD","LU0577902298.EUR","JADE","LU1439102457.SGD","LU0106959298.USD","LU0417516738.SGD","688981","LU0328353924.USD","IE0003795394.USD","LU1568876251.USD","300308","LU0516423091.SGD","LU0898667661.SGD","LU0469268626.HKD","LU1725190679.HKD","LU0823040885.USD","LU2476274308.USD","LU0642271901.SGD","LU1255011170.USD","LU0359202008.SGD","LU0531971595.HKD","LU0791590937.USD","IE00B97KM107.HKD","LU2317271919.USD","LU1282649141.HKD","AAXJ","LU1769817096.USD","LU1201861165.SGD","SG9999015978.USD","LU2247934214.USD","LU1868838027.USD","IE00BPRC5H50.USD","LU1880383366.USD","BK1576","SG9999000459.SGD","LU0117841782.USD","LU0831103253.SGD","LU2399975544.HKD","LU1105468828.SGD","00700","SGXZ90724238.SGD","SG9999013353.USD","LU0327786744.USD","LU0823397285.USD","LU1316542783.SGD","SG9999001093.SGD","LU0143863198.USD","LU2237443382.USD","LU2008162690.USD","LU0211331839.USD","LU0882747503.HKD","HK0000151867.HKD","LU0577902538.SGD","LU0072913022.USD","HSTECH","BK1584","LU0831093199.SGD","LU0823038988.USD","LU0130103400.USD","HK0000306701.USD","HK0000914686.HKD","LU0762541174.USD","SG9999014898.SGD","IE00B067MR52.USD","SG9999002463.SGD","LU0326948709.USD","SG9999014674.SGD","LU0049853897.USD","LU1880398554.USD","LU0819123356.HKD","IE00BZ08YR35.GBP","BK1117","LU0499858438.USD","LU1868837565.USD","LU0211977185.USD","BK1193","LU1733274390.USD","LU0011963245.USD","XIACY","LU2778985437.USD","LU2279858448.HKD","LU0049112450.USD","IE00B031HY20.USD","00100","SG9999015945.SGD","LU1974910355.USD","LU1226287792.SGD","GAMR","LU1794554557.SGD","LU2133065610.SGD","LU0633140727.USD","LU0823397103.USD","LU0823426480.USD","LU0456827905.SGD","LU0823039010.USD","LU0173614495.USD","LU1642822792.SGD","LU0633140560.USD","MIUmain","LDEM","LU0192582467.USD","TCEHY","LU1044874839.SGD","LU0048580855.USD","LU0871576103.HKD","BK1591","LU2148510915.USD","LU0868486357.SGD","LU2242644610.SGD","LU0611395673.USD","LU0880133367.SGD","LU0456846285.SGD","LU0348784397.USD","LU0588545730.USD","LU0594300179.USD","BK1575","03423","LU0307460666.USD","IE0003895053.USD","LU0348723411.USD","LU0675040207.SGD","LU0175139822.USD","LU0348825331.USD","LU1064130708.USD","LU1008478684.HKD","LU0640798160.USD","BK1531","LU1629966141.USD","HK0000306685.HKD","LU0143863784.USD","IE00B5MMRT66.SGD","LU0048388663.USD","DRGN","LU2125910500.SGD","LU2097828805.USD","IE0008369823.USD","SG9999001846.SGD","LU0431992006.USD","LU0345769128.USD","LU0540923850.HKD","LU1226288170.HKD","TCHI","IE0034224299.USD","LU2087589342.USD","BK1516","LU1515016050.SGD","LU1226287875.USD","BK1588","HBBD.SI","LU2251237488.HKD","LU2097828631.EUR","LU1720051108.HKD","03067","LU0873338254.USD","HK0000320264.USD","LU0593848301.USD","LU0594300419.USD","LU1224444064.USD","IE00B0169L03.USD","LU0608807433.USD","EMCS","LU1152091168.USD","LU1048484197.HKD","LU0348827113.USD","BK1523","LU0203347892.USD","LU1956131251.USD","LU0345775950.USD","LU0651947912.USD","LU1804176565.USD","LU0345776255.USD","LU2476274720.SGD","LU0210527791.USD","LU1282648689.USD","LU0543330566.HKD","IE00BMPRXR70.SGD","IE0008368411.USD","LU0572939691.SGD","BK1608","SGXZ51526630.SGD","LU1323998911.USD","LU0052750758.USD","LU2097828557.USD","LU2362541513.USD","LU0797268264.HKD","LU0572940350.SGD","03308","LU0048597586.USD","LU0878004406.USD","IE0031814852.USD","LU1655091459.SGD","LU1044875133.USD","LU2177674079.SGD","601869","LU1051769294.HKD","LU0320764755.SGD","01810","HXXD.SI","LU1770034418.SGD","LU2929501877.USD","LU0700851271.USD","LU0501845795.SGD","LU0890818403.SGD","IE00B031J352.USD","LU1188198961.HKD","LU1691799644.USD","BK1249","FFEM","BK1517","LU0516423174.USD","LU1196710195.USD","LU0329678170.USD","MCHS","03033","LU0577902611.USD","IE00BF5LJ272.USD","LU0918141705.HKD","LU0072462343.USD","LU1675838814.USD","SG9999004220.SGD","LU2237443465.HKD","LU1282649067.USD","IE00B031HW06.USD","IE00B543WZ88.USD","LU0214875030.USD","LU1282651121.HKD","LU2237443978.SGD","HTCD.SI","LU1282651048.USD","LU1785774172.SGD","BK1614","LU0070217475.USD","LU1719994722.HKD","LU0289960550.SGD","LU0197773673.USD","LU0417516571.SGD","LU1720050803.USD","LU0203345920.USD","LU1568876335.HKD","IE00B3M56506.USD","LU1046422090.SGD","EMC","LU0878005551.USD","IE00BZ08YS42.EUR","SGXZ99366536.SGD","BK1589","LU0762542818.HKD","LU0348735423.USD","SOCL","LU2051468812.USD","IE00BGV7N243.SGD","LU0106259558.USD","IE00BQXX3F31.USD","LU0345769631.USD","IE00B29SXG58.USD","XSOE","LU0228659784.USD","LU0163747925.USD","LU0107464264.USD","LU0683595622.HKD","LU1115378108.SGD","LU0630378692.HKD","LU1718418525.SGD","LU0455707207.USD","LU0488056044.USD","SG9999001069.SGD","09988","BK1170","FDNI","FPA","LU0196878994.USD","LU0261947096.USD","LU2152927971.USD","03088","LU2097828714.EUR","LU0251144936.SGD","ESPO","SG9999001903.USD","CXSE","BK1586","BIDD","LU2488822045.USD","LU1303224171.USD","LU0396098781.USD","BK1521","LU0449509016.USD","LU1235295612.USD","LU2462611646.USD","HK0001040143.USD","02513","LU0348783662.USD","LU0261950983.USD","LU1023057109.AUD","LU1328277881.USD","LU1951186391.HKD","LU1548497426.USD","LU1242518857.USD","02837","LU0791591158.USD","IE00B8HQ1Z84.USD","02269","IE00B0JY6N72.USD","LU0359201612.USD","LU0348805143.USD","06869","LU1242518931.SGD","HK0000320223.HKD","LU2039709279.SGD","LU0561508036.HKD","LU0029874905.USD","LU0650527681.SGD","LU2226246903.HKD","EEMX","LU0106252389.USD","LU1251922891.USD","SG9999001051.SGD","KWEB","LU0588546209.SGD","LU1868837722.USD","KURE","LU0080751232.USD","LU0165289439.USD","HK0000288743.USD","LU0762540952.USD","LU0634319403.HKD","LU0588545904.SGD","SG9999006597.SGD","LU0477156797.USD","LU0786609619.USD","LU0541501648.USD","LU0541502299.USD","09067","IE00B0169N27.USD","LU0370786039.SGD","TCHmain","LU0130518102.USD","LU0449515922.USD","GB00BDT5M118.USD","LU1831875114.USD","LU2257852520.SGD","LU2237443622.USD","01888","LU1224709979.USD","LU1961090484.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870226","title":"【生物医药小白投研】第八篇:小白完整投研框架与体系复盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870226","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664870226?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:10","pubTimestamp":1788423000,"startTime":"0","endTime":"0","summary":"经过前七篇的认知、排雷、管线、赛道、BD、估值、交易节奏全维度学习,本篇作为专栏终章,复盘整套投研体系,整合核心知识点,帮助新手建立系统化的投资决策习惯。对仅有纸面高额交易额、低首付、小公司噱头BD的标的保持警惕。作者丨吴言编辑丨Jasmine往期推荐:第七篇:看得懂基本面,更要把握交易节奏第六篇:小白也能上手的医药股估值与前景打分体系第五篇:读懂BD的价值逻辑第四篇:分清黄金赛道与内卷红海","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI2MDAzMTQ4OA==&mid=2650514079&idx=1&sn=b343b5c979b09868c5b4b6ffa6bf3616&chksm=f3613873bcb2e49ac858ccd3d88ca34c5f10e2143037b5c049e758da1d990257cd4b54d9d0b6&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["LU2097828631.EUR","BK1500","BK1515","LU0067412154.USD","KURE","LU1251922891.USD","LU0880133367.SGD","LU1960683339.HKD","LU0828237510.HKD","LU1813983027.USD","SG9999004220.SGD","LU0348735423.USD","02269","LU0455707207.USD","LU0856984785.SGD","03692","LU0359202008.SGD","LU1880383366.USD","LU1720050803.USD","IE00BZ08YT58.USD","LU2488822045.USD","LU2097828474.EUR","IE00B0JY6N72.USD","LU1794554557.SGD","01801","LU0181495838.USD","LU0320764599.SGD","06160","HK0000165453.HKD","LU1807302812.USD","LU0359201612.USD","LU1008478684.HKD","LU2039709279.SGD","LU1328277881.USD","LU0244354667.USD","LU0051755006.USD","LU1188198961.HKD","LU0128526141.USD","LU1969619763.USD","BK1583","LU0456846285.SGD","01530","BK1588","LU0072913022.USD","LU0516423174.USD","01093","LU0029874061.USD","LU2242644610.SGD","LU0572944931.SGD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.0886},{"period":"3month","weight":0.6369},{"period":"6month","weight":0.3834},{"period":"1year","weight":0.347},{"period":"ytd","weight":0.563}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.0173},{"period":"6month","weight":-0.0426},{"period":"1year","weight":-0.0557},{"period":"ytd","weight":-0.0278}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联(XDC)分部主要从事为抗体偶联药物(ADCs)及各种生物偶联药物提供合同研究、开发及生产组织(CRDMO)服务。该公司主要在国内和国外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052868},{"month":2,"riseRate":0.555556,"avgChangeRate":0.006907},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.001977},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000488},{"month":5,"riseRate":0.555556,"avgChangeRate":0.002485},{"month":6,"riseRate":0.666667,"avgChangeRate":0.061606},{"month":7,"riseRate":0.7,"avgChangeRate":0.085288},{"month":8,"riseRate":0.6,"avgChangeRate":0.053299},{"month":9,"riseRate":0.7,"avgChangeRate":0.051318},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}